Providence Wealth Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $875K | Sell |
10,914
-81
| -0.7% | -$6.5K | 0.6% | 48 |
|
2025
Q1 | $956K | Buy |
10,995
+617
| +6% | +$53.6K | 0.72% | 45 |
|
2024
Q4 | $1.04M | Sell |
10,378
-66
| -0.6% | -$6.59K | 0.78% | 44 |
|
2024
Q3 | $1.11M | Buy |
10,444
+290
| +3% | +$30.9K | 0.82% | 41 |
|
2024
Q2 | $1.31M | Buy |
10,154
+280
| +3% | +$36K | 1.04% | 32 |
|
2024
Q1 | $1.29M | Buy |
9,874
+302
| +3% | +$39.3K | 1.1% | 31 |
|
2023
Q4 | $1.22M | Buy |
9,572
+511
| +6% | +$65.1K | 1.1% | 28 |
|
2023
Q3 | $924K | Buy |
9,061
+175
| +2% | +$17.9K | 1.03% | 32 |
|
2023
Q2 | $1.01M | Sell |
8,886
-825
| -8% | -$93.8K | 1.12% | 30 |
|
2023
Q1 | $1.11M | Buy |
9,711
+96
| +1% | +$10.9K | 0.82% | 41 |
|
2022
Q4 | $1.09M | Buy |
9,615
+125
| +1% | +$14.2K | 0.81% | 40 |
|
2022
Q3 | $976K | Sell |
9,490
-173
| -2% | -$17.8K | 0.73% | 44 |
|
2022
Q2 | $901K | Buy |
9,663
+923
| +11% | +$86.1K | 0.65% | 49 |
|
2022
Q1 | $730K | Buy |
8,740
+215
| +3% | +$18K | 0.47% | 62 |
|
2021
Q4 | $685K | Hold |
8,525
| – | – | 0.43% | 67 |
|
2021
Q3 | $703K | Buy |
8,525
+300
| +4% | +$24.7K | 0.49% | 59 |
|
2021
Q2 | $643K | Buy |
8,225
+66
| +0.8% | +$5.16K | 0.44% | 62 |
|
2021
Q1 | $600K | Buy |
8,159
+1,268
| +18% | +$93.2K | 0.44% | 63 |
|
2020
Q4 | $530K | Buy |
6,891
+809
| +13% | +$62.2K | 0.44% | 62 |
|
2020
Q3 | $481K | Buy |
6,082
+2,618
| +76% | +$207K | 0.48% | 60 |
|
2020
Q2 | $256K | Buy |
+3,464
| New | +$256K | 0.26% | 80 |
|
2019
Q2 | – | Sell |
-2,568
| Closed | -$205K | – | 83 |
|
2019
Q1 | $205K | Buy |
+2,568
| New | +$205K | 0.19% | 83 |
|